Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
In the Phase 3 ATTAIN-1 trial, orforglipron 36 mg reduced weight by an average of 12.4% (27.3 lbs) compared to 0.9% with placebo at 72 weeks
This assessment identifies which areas are accelerating fastest and likely to reshape the competitive landscape over the coming years
Lebon, T
When the diabetes drug sitagliptin went off patent in 2022, about 30 branded versions appeared within a month and nearly 100 within a year
US$ 22.80
US$ 26.05
US$ 21.49
US$ 26.74
US$ 25.30
US$ 29.33
US$ 29.95
US$ 29.94
US$ 24.20
